Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yangshengtang Pharmaceutical is a leading Chinese healthcare and pharmaceutical company, serving as a core pillar of the Yangshengtang Group. The company is widely recognized for its dominant position in the consumer health market, particularly for its natural Vitamin E and Vitamin C supplements. Beyond nutrition, the company operates extensively in the biotechnology sector through its subsidiary, Beijing Wantai Biological Pharmacy, which developed the world's first Hepatitis E vaccine and China's first domestically produced HPV vaccine. Yangshengtang integrates research, production, and sales, focusing on infectious disease prevention, diagnostics, and nutritional health. The company maintains large-scale manufacturing bases in Hangzhou, Hainan, and Beijing to support its diverse portfolio of OTC medicines and biological products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yangshengtang Pharmaceutical.